Published 2 days ago • loading... • Updated 1 day ago
Commercial Demand for Microgravity Drug Discovery Accelerates as Exobiosphere and Voyager Technologies Add Two Missions to the ISS
Summary by Green Stock News
3 Articles
3 Articles
Voyager and Exobiosphere Expand Microgravity Drug Research with Two New ISS Campaigns
Voyager Technologies and Exobiosphere have added two research campaigns aboard the International Space Station, expanding their partnership as they work to establish a recurring model for pharmaceutical and biotechnology research in microgravity.
Biotech Research in Microgravity: Experiment Campaigns Outlined
Commercial biotech research in microgravity got another boost by the expansion of an agreement between Exobiosphere and Voyager Technologies. Two additional research campaigns will be carried out aboard the International Space Station (ISS). Exobiosphere’s Orbital High-Throughput Screening in Microgravity (OHTS) platform is a mid-deck-locker-class system for automated drug screening. The OHTS is scheduled for installation […]
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium






